Fusion Biopsy for Prostate Cancer Diagnosis
The latest technological diagnostic methods such as Prostate Fusion Biopsy make you laugh in the treatment of prostate cancer, which is increasing day by day. Prostate Fusion Biopsy from the prostate gland, which has previously been taken blindly, can be performed on targeted MRI from suspicious areas detected on MRI. Thus, treatment can be planned more accurately by making a more accurate diagnosis.
Currently, the standard diagnostic method for prostate cancer is limited. Compared to the autopsy series, the sensitivity of the prostate biopsy is around 50 percent. Due to this uncertainty, approximately one third of the patients had to go back to biopsy within 5 years, and 13 to 41 percent of them had a tumor. In order to overcome these problems, the biopsies in which more sampling is offered, the rate of clinically meaningless tumor arrest increases and therefore an increase in the risk of unnecessary treatment occurs.